Ruegsegger Frederick J 4
4 · Transcept Pharmaceuticals Inc · Filed Sep 13, 2011
Insider Transaction Report
Form 4
Ruegsegger Frederick J
Director
Transactions
- Purchase
Common Stock
2011-09-13$2.86/sh+15,000$42,933→ 15,000 total
Footnotes (1)
- [F1]The purchase price reported in column 4 of Table 1 represents the weighted average purchase price of the shares purchased ranging from $2.83 to $2.89 per share. Upon request of the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.